Healio

Cornea specialists compare management approaches for neurotrophic keratitis

Please provide your email address to receive an email when new articles are posted on . Welcome to another edition of CEDARS/ASPENS Debates. CEDARS/ASPENS is a society of cornea, cataract and ...
Healio

Minimally invasive corneal neurotization effective for neurotrophic keratopathy

CHICAGO — Minimally invasive corneal neurotization was successful in treating neurotrophic keratopathy, according to a speaker here. Older techniques for corneal neurotization, in which an intact ...
Business Wire

rhNGF, the Dompé Biotech Molecule for the Treatment of Neurotrophic Keratitis, Receives Orphan Drug Designation from the European Medicines Agency

• The drug, discovered and developed in Italy, is being studied in patients with neurotrophic keratitis, a pathology still lacking an effective treatment that affects fewer than five out of 10,000 ...
News Medical

Dompé’s investigational biotech molecule receives orphan drug designation for treatment of neurotrophic keratitis

The Dompé biopharmaceutical company announced today that the Committee for Orphan Medicinal Products of the European Medicines Agency (EMA) has officially designated recombinant human Nerve Growth ...
Ophthalmology Times

IRIS Registry data mined for understanding of pediatric NK

Searching the IRIS Registry for the years 2016 to 2022, they found data entered for 67,855,466 patients. Applying the ICD ...
Medscape

Which Regenerative Methods Are Used for Healing the Cornea?

In ophthalmology, there are several approved, biotechnologically manufactured, regenerative medicine products that are used as eye drops or as transplants for corneal diseases. Gerd Geerling, MD, PhD, ...
UPI

FDA approves first drug to treat rare corneal eye condition

Aug. 23 (UPI) --The U.S. Food and Drug Administration approved the first medication to treat a rare eye disease affecting the cornea. Dompe farmaceutici SpA, an Italian bio-pharmaceutical company, can ...
News Medical

FDA approves first drug for treatment of rare disease affecting the cornea

Neurotrophic keratitis is a degenerative disease resulting from a loss of corneal sensation. The loss of corneal sensation impairs corneal health causing progressive damage to the top layer of the ...
Medscape

FDA Clears First Drug for Neurotrophic Keratitis

The US Food and Drug Administration (FDA) has approved cenegermin (Oxervate, Dompé Farmaceutici S.p.A.), the first drug to treat neurotrophic keratitis. Neurotrophic keratitis is a rare degenerative ...
EurekAlert!

Advances in corneal healing research drive new treatments for rare eye diseases

In vivo laser axotomy of a single subbasal fiber (SBF) in an adult mouse. The Ocular Neurobiology laboratory at the Institute for Neurosciences, a joint center of Miguel Hernández University (UMH) in ...
PR Newswire

Neurotrophic Keratopathy Market to Grow Rapidly at a CAGR of 15.4% by 2032, Predicts DelveInsight

The dynamics of the neurotrophic keratopathy market are expected to increase in the forecast period. Compared to 2019, massive growth is expected in the 7MM neurotrophic keratopathy market. Along with ...